Alibaba Health Information Technology Ltd

00241

Company Profile

  • Business description

    Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

  • Contact

    Guanghua Road
    65th Floor, CITIC Tower, Building 1, No.10 Courtyard
    Jianwai Subdistrict, Chaoyang District
    Beijing
    CHN

    https://www.alihealth.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2026

    Employees

    1,422

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,770.6025.40-0.29%
CAC 407,684.6880.43-1.04%
DAX 4023,516.23255.22-1.07%
Dow JONES (US)42,197.79769.83-1.79%
FTSE 1008,850.6334.29-0.39%
HKSE23,892.56142.82-0.59%
NASDAQ19,406.83255.66-1.30%
Nikkei 22537,834.25338.84-0.89%
NZX 50 Index12,552.8796.23-0.76%
S&P 5005,976.9768.29-1.13%
S&P/ASX 2008,547.4017.70-0.21%
SSE Composite Index3,377.0025.66-0.75%

Market Movers